Cytocell
Oxford Gene Technology (OGT) is a leading global provider of diagnostic genomic solutions, committed to enabling researchers and clinical decision makers to make accurate and effective decisions for each patient. With a focus on innovation in NGS, arrays, and FISH technologies, OGT aims to improve the future of genetic clinical care through collaboration, quality, and social responsibility. The company has a rich history of scientific innovation, including the invention of the Southern blot and the development of microarrays, and operates in over 87 countries with a strong emphasis on quality assurance and information security.
Industries
Nr. of Employees
small (1-50)
Cytocell
Unit 5, Oxford Technology Park, 4A Technology Drive, Kidlington, Oxfordshire, OX5 1GN, UK
Products
FISH probe kits and consumables
Hybridisation-based FISH probe kits and related consumables for cytogenetic and molecular pathology applications.
Targeted NGS panel kits and library preparation reagents
Preconfigured targeted NGS panels for oncology and constitutional genetics with associated library preparation reagents and workflows.
aCGH microarray products and labelling kits
Comparative genomic hybridisation microarrays and genomic DNA labelling kits for copy-number and SNP analysis.
NGS data analysis software and bioinformatics tools
Software and computational pipelines for analysis and interpretation of targeted NGS and microarray data.
FISH probe kits and consumables
Hybridisation-based FISH probe kits and related consumables for cytogenetic and molecular pathology applications.
Targeted NGS panel kits and library preparation reagents
Preconfigured targeted NGS panels for oncology and constitutional genetics with associated library preparation reagents and workflows.
aCGH microarray products and labelling kits
Comparative genomic hybridisation microarrays and genomic DNA labelling kits for copy-number and SNP analysis.
NGS data analysis software and bioinformatics tools
Software and computational pipelines for analysis and interpretation of targeted NGS and microarray data.
Services
Collaborative partnerships to support clinical assay and companion diagnostic development for oncology and haematological indications, including assay design, validation support and regulatory coordination.
Onsite and remote technical support, demonstrations, evaluations and training to implement assays and optimise laboratory workflows.
Project-based design services for bespoke FISH probes, targeted NGS panels and custom aCGH arrays tailored to customer requirements.
Collaborative partnerships to support clinical assay and companion diagnostic development for oncology and haematological indications, including assay design, validation support and regulatory coordination.
Onsite and remote technical support, demonstrations, evaluations and training to implement assays and optimise laboratory workflows.
Project-based design services for bespoke FISH probes, targeted NGS panels and custom aCGH arrays tailored to customer requirements.
Expertise Areas
- Cytogenetics and FISH probe development
- Targeted NGS assay development and reagent workflows
- Microarray (aCGH) design and production
- Clinical and analytical validation study design and execution
Key Technologies
- Fluorescence in situ hybridisation (FISH)
- Targeted next-generation sequencing (NGS) panels
- NGS library preparation workflows
- Comparative genomic hybridisation microarrays (aCGH)
News & Updates
Moving from plastic to sustainable packaging for CytoCell products, supporting environmental efforts.
Unlocks more efficient genetic profiling for CLL samples, improving upon existing technology.
Streamlines NGS process for faster results in myeloid cancer research.
Patent Coverage in Genomics and Microarrays
OGT holds patents including EP 2,521,794; US 9,587,278, covering microarrays and genomics.
Moving from plastic to sustainable packaging for CytoCell products, supporting environmental efforts.
Unlocks more efficient genetic profiling for CLL samples, improving upon existing technology.
Streamlines NGS process for faster results in myeloid cancer research.
Patent Coverage in Genomics and Microarrays
OGT holds patents including EP 2,521,794; US 9,587,278, covering microarrays and genomics.